## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |ESIGNATED FUNDS A list ofdesignate|ESIGNATED FUNDS A list ofdesignate|ESIGNATED FUNDS A list ofdesignate|d
funds
held during 2022—|d
funds
held during 2022—|2023| |---|---|---|---|---|---| |Women's
General Purpose|||Community
midwifery||| |Fundraising|||Miscarriage
Fund||| |Kings Fund|||Medical Education|Fund|| |Bereavement/Honeysuckle|||MRCOG||| |Arts for Health|||Cancer Research|Fund|| |Anaesthetic|Fund||Staff Welfare Fund||| |Reproductive|Medicine|Unit Fund|Liverpool Fetal Fund||| |Gynae Oncology Nurses||Fund|Neonatal||| |Twin Birth|||Training
and Development||| |Maternity|||Assisted Conception||Fund| ||||Cytogenetics
Fund||| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||||||Unrestricted|Restricted|Total|Total| |---|---|---|---|---|---|---|---|---|---| |||||||Funds|Funds|Funds|Funds| |||||Note||2023|2023|2023|2022| |||||||6000|6000|6000|6000| |Incoming resources:|||||||||| |Income and endowments||from:|||||||| |Donations
and legacies||||||290||290|226| |Other trading
activities||||||53||53|33| |Investments|||||13|21||21|20| |Other income||||||0||0|0| |Total incoming resources||||||364||364|279| |Resources expended:|||||||||| |Expenditure
on:|||||||||| |Raising funds||||||184||184|124| |Charitable
activities||||||224||224|112| |Total resources expended||||||408|0|408|236| |Net expenditure
before investment
gains/(losses)||||||(44)|0|(44)|43| |Net (loss) / gain on investments|||-unrealised||12|(90)|0|(90)|(52)| |Net gains on investments||—realised||||10|0|10|67| |Net (expenditure)/income||||||(124)|0|(124)|58| |Net movement
in funds||||||(124)|0|(124)|58| |Reconcigation
ofFunds:|||||||||| |Fund balances
brought|forward||1a April|||562|0|562|504| |Fund balances carried|forward||31n March|||438||438|562| ## |Balance|Sheet as|at 31st March 2023||||| |---|---|---|---|---|---|---| |||||Unrestricted
Funds|Total Funds|Total Funds| ||||Note|2023|2023|2022| |||||6000|6000|9000| |Fixed assets:||||||| |Investments|||12|814|814|912| |Total fixed assets||||814|814|912| |Current assets:||||||| |Debtors|||14|||| |Cash at bank|and
in hand||15|||| |Total current|assets|||14|14|| |Liabilities:||||||| |Creditors
and|commitments|falling due within one year|16|(248)|(248)|«36)| |Creditors
and|commitments|due greater than one year||«42)|142|225| |Total current|liabilities|||(390)|390|361)| |Net current assets/(liabilities)||||(376)|(376)|(350)| |Total assets|less current|liabilities||438|438|562| |The funds of|the charity:|||||| |Unrestricted
funds|||17|436|438|562| |Total charity|funds|||438|438|562| ## |Statem|ent ofCash|Flo|ws|for|th|e year ended|31st March 2023||| |---|---|---|---|---|---|---|---|---|---| |||||||||Total|Total| |||||||||Funds|Funds| ||||||||Note|2023|2022| |||||||||f000|8000| |Cash flows from operating||activities:|||||||| |Net cash|provided
by operating||activities||||18|(115)|(25)| |Cash flows from investing||activities:|||||||| |Dividends|and interest from|investments||||||21|20| |Proceeds|from sale of investments|||||||371|194| |Purchase|of investments||||||12|(283)|(174)| |Net cash|provided
by/(used|in)|Investing||activities|||109|40| |Change
in|cash and cash equivalents|||in|||||| |the reporting
period||||||||(8)|15| |Cash and|cash equivalents|at the beginning||||of|||| |the reporting
period||||||||28|13| |Total cash and cash equivalents|||at the end|||of|||| |the reporting
period|||||||19|22|28| ## |Notes to the accounts||||||||||| |---|---|---|---|---|---|---|---|---|---|---| |1. Accounting
Pogcies||||||||||| |1.1.Legal Status||||||||||| |The Liverpool Women's
NHS Foundation
Charitable
Trust|is an unincorporated
charity registered
with the charity commission.|||||The||address||is| |Crown Street, Liverpool,
LS7SS.||||||||||| |1.2.Basta ofpreparation||||||||||| |The financial
statements
have been prepared
under the historic cost convention,
with the exception of||investments
which||are||included|||at|fair| |value. The financial statements
have been prepared
in accordance
with the Statement
of Recommended|||Practice: Accounting||||and|Reporting||| |by Charities
prepariing
their accounts
in accordance
with
(FRS102)issued on July 2014, and the Financial
Reporting|the
Financial
Reporting
Standard
applicable
in the
UK and
Republic
of Ireland
Standard
applicable
in the United
Kingdom
and Republic of Ireland (FRS102) and|||||||||| |the Charities Act 201I and UK Generally Accepted Practice|as it applies from
1 January 2019.|||||||||| |The Trustee considers
that there are no material
uncertainties
about the Chai'ity's
ability to continue as a|||going concern. There|||are no material||||| |uncertainties
affecting
the current
years accounts. The Charity
has recently
reviewed
its Investment|||policy thoroughly|with|||its Investment|||| |advisors
Investec Wealth
and Management
and
will continue to monitor
and react accordingly
to the changes
in the financial
was a net decrease
in the closing fund balance
in 2022/23 off124 from f562k at 1stApril 2022 to 2438k st 31st March 2023.||||||markets.|||There|| |The Charity constitutes
a public benefit entity as defined
by FRS 102.The financial
statements
are prepared
in sterling
which|||||is||the functional|||| |currency ofthe entity.||||||||||| |1.3.Funds structure||||||||||| |Unrestricted
funds
comprise those funds which
the Trustee
is free to use for any purpose
in furtherance|||of the charitable|objects.||||Restriicted||| |funds comprise those funds where the donor has provided|for the donation
to be spent in furlherance
of|a specified charitable|||purpose.|||||| |The funds held are disclosed
in note 17.||||||||||| |1.4.Incoming resources||||||||||| |Ag incoming
resources are recognised
ance the Charity has entitlement
to the resources,
it is probable
that the resources||||will|be received and|||||| |the monetary
value of incoming resources can be measured|with sufficient
reliability|||||||||| |Where there are terms or conditions
attached
to incoming|resources,
particularly
grants,
then these terms or conditions|||must|||be|met|before|| |the income is recognised
as the entitlement
condition
will|not be satisfied
until that point.
Where terms or conditions
have||||not been||||met|or| |uncertainty
exists as to whether
they can be met then
the relevant
income
is not recognised
in the||year but deferred||and|||shown||on|the| |balance sheet as deferred
income.||||||||||| |1.5.Incoming resources from
legacies||||||||||| |Legacies are accounted
for as incoming
resources
either|upon receipt or where
the receipt of the legacy is probable.|||Receipt is probable||||||| |when:||||||||||| |Confirmation
has been received
from the representatives|ofthe estate that probate has been granted|||||||||| |The executors have established
that there are sufficient|assets in the estate to pay the legacy, and|||||||||| |All conditions
attached to the legacy have been fulfilled|orare within the charity's
control|||||||||| |Ifthere is uncertainty
as to the amount
of the legacy and
it|cannot be reliably estimated
then the legacy|is shown as a contingent|||||asset||until|ag| |ofthe conditions for income recognition
are met.||||||||||| |1.6.Resources expended
and irrecoverable
VAT||||||||||| |Ag expenditure
ls accounted for on an sccruals basis and has been classified under headings
that aggregate
ag costs relating|||||to||each category|||| |ofexpense shown
in the Statement of Financial Activities|Expenditure
is recognised
when the following||criteria are met:|||||||| |There is a present
legal or constructive
obligation
resulting
from a past event||||||||||| |It is more likely than not that a transfer ofbenefits
(usuagy a cash benefit) will be required
in settlement||||||||||| |The amount ofthe obligation
can be measured
or estimated
reliably||||||||||| ## ## ## ## ## ## |Fund||||||||Purpose|||||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---| |The Women's|Hospital||General|||Purpose|Fund|Any chantable
purpose(s)
relating
to the NHS wholly
Hospital|or mainly|for the|Liverpool||Women' s| |Liverpool Women's||Cancer|||Charity|||To further
the advancement
of scientific and medical
related to cancer research.|education|and|research||into topics| |Community
Midwifery||||||||Promoting
the efficient performance
of their duties
by
TrusL|the midwives
of the NHS|||Foundation|| |Reproductive|Medicine|||Fund||||To further
tha advancement
of scientific
and medical
related to infertility,
miscarriage
and menopause.|education|and|research||into topics| |Medical Education||Fund||||||To further
the advancement
of scientific
and
medical
related to the field ofobstetdics and gynaecology.|education|and|research||into topics| |Fetal Centre|Research||and||Development|||The investigation
into causes ofsickness
in the unborn
cure and defeat ofthis sickness.|child and|the prevention,|||treatment,| |||||||||The investigation
into
the causes
of sickness
in the|newborn|child|and
the|prevention,|| |NeonatalFund||||||||treatment,
cure and defeat of this sickness
and to further
the cause of premature
newborn
babies
at the
NHS
Foundation
Trust
and
to further
the advancement
of scientific
and|||||| |||||||||medical education
and research
into topics related to sickness
in||the newborn
child.|||| |Other Funds:|||||||||||||| |Women's
Hospital||Staff||Welfare||Fund||For the relief ofsickness by promoting
the efficient performance
oftheir
the Liverpool Women's
Hospital.|||duties by||the staff of| |||||||||To further
the advancement
of scientific
and
medical|education|and|research||into topics| |Training
and|Development||||Fund|||relating
to
pregnancy
and
problems
associated
with
giving||birth|and
gynaecological||| |||||||||problems.|||||| |Women's Assisted||Conception||||Fund||To further the advancement
ofscientific and medical education
into topics related
in women.|||||to infertility| |Cytogenetics|Fund|||||||To further
the advancement
of scientific
and
medical
related to cytogenetics|education|and|research||into topics| ## |4.Analysis ofInco|me||||||| |---|---|---|---|---|---|---|---| |||||2023|2023|2023|2022| |||||Unrestricted|Restdicted|Total|Total| |||||Funds|Funds|Funds|Funds| |||||6000|6000|6000|6000| |Donations
and legacies;|||||||| |Donations
and gifts||||285||285|204| |Legacies||||5||5|22| |Total donations
and legacies||||290|0|290|226| |Other trading
activities:|||||||| |Stall income||||34||34|25| |Fundraising
events||||19||19|8| |Total other trading|activities|||53||53|33| |Income from investments:|||||||| |Dividend
income||||21||21|20| |Total income from|investments|||21|0|21|20| |Other income:|||||||| |Total other income|||||0|0|| |Total Income||||364|0|364|279| |AO income
in the current and||prior year was unresiricted.|||||| |5.Donated Goods|||||||| |||||2023|2023|2023|2022| |||||Unrestricted|Restricted|Total|Total| |||||Funds|Funds|Funds|Funds| |||||6000|6000|f000|6000| |Included
within other trading|||activities:||||| |Sale ofdonated
items||||34||34|25| |Total stall income|included|within other|||||| |trading
activities||||34||34|25| ## ## |7.1 Support 8 Governance|7.1 Support 8 Governance|Costs|Costs||||||| |---|---|---|---|---|---|---|---|---|---| |||||||2023|2023|2023|2022| |||||||Unrestricted|Restricted|Total|Total| |||||||Funds|Funds|Funds|Funds| |||||||5000|8000|6000|5000| |Support
Women's|Costs: Financial Services
NHS Foundation
Trust||provided|by|Liverpool|19||19|19| |Governance Costs: Independent|||Examination||Fees||||| |Total||||||21|0|21|21| |7.2 Apportionment|7.2 Apportionment|ofSupport &Governance|ofSupport &Governance|ofSupport &Governance|ofSupport &Governance|ofSupport &Governance|ofSupport &Governance|Costs across Charitable|Activities|||||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||||||2023|2023|||2023|2023|2022| |||||||||Patient welfare|Staffwelfare||Equipment
and
Research||Total|Total| |||||||||FOOO|6000|||5000|5000|5000| |Support Costs: Financial
Liverpool Women's
NHS|||Services provided
Foundation
Trust||||by|10|||||19|19| |Governance|Costs: Independent||||Examination|||||||||| |Fees||||||||||||||| |Total||||||||||10|||21|21| |7.3Analysis|ofexpenditure|||||||||||||| |||||||||2023|2023|||2023|2023|2022| |||||||||Unrestricted|Unrestricted||Restricted||Total|Total| |||||||||Funds|Funds||Funds|||| ||||||||||Support|&||||| ||||||||||Governance|||||| ||||||||||Costs|||||| |||||||||6000|f000|||8000|f000|6000| |Expenditure|on raising||funds:|||||||||||| |Staging fundraising||events||||||56|||||56|13| |Fundraising|team|costs||||||120|||||120|102| |Investment|management||costs|||||8|||||8|9| |Total expenditure||on raising funds||||||184|||||184|124| |Expenditure|on charitable|||activities:||||||||||| |Patient welfare||||||||90||11|||101|66| |Staff welfare||||||||94||9|||103|45| |Equipment||||||||20||0|||20|1| |Research||||||||0||0|||0|0| |Total expenditure||on charitable|||activities|||204||20||0|224|112| |Total Expenditure||||||||388||20||0|408|236| |8.Independent
examination|8.Independent
examination|and audit fees| |---|---|---| |Fees for examination|ofthe|accounts:| |Independent
examiner's|fees|| |Total fees||| ## ## |Please refer to the Trustee's
Annual|Please refer to the Trustee's
Annual|report to the Account for additional|information|on the grant making|activities performed|duding|the year to| |---|---|---|---|---|---|---|---| |31stMarch 2023.|||||||| |11.Transfers between funds|||||||| |There were no transfers
between|funds during 2022/23 (2021/22:fnil).||||||| |12.Fixed asset investments|||||||| ||||||2023||2022| |Movement
in fixed asset investment|||||Total||Total| ||||||f000||8000| |Market Value brought
forward|||||892||897| |Add: additions
to investment
at cost|||||283||174| |Less: disposals at carrying
value|||||(282)||(127)| |Add: net (loss) / gain on revaluation||-unrealised|||(90)||(52)| |Market Value as at 31 March|||||803||892| |Cash held as part of investment|ponfolio||||||20| |Total investment
value as at 31 March|||||814||912| |Historic Cost as at 31 March|||||729||708| ||||||2023|2022| |---|---|---|---|---|---|---| |Fixed asset Investments||by type|||Total|Total| ||||||8000|f000| |Investments
lisled|on a recognised||Stock|||| |Exchange:||||||| |UK Equities|||||183|315| |European
equities|||||64|37| |North Amedican|equities||||184|201| |Japanese
equities|||||14|15| |Fsr East and Australasian||equities|||16|26| |Emerging
economies|||||33|18| |International
equities|||||29|14| |Properly|||||43|50| |Alternative
Assets|||||72|70| |Other investments:||||||| |UK fixed interest|||||92|123| |Overseas
Fixed|Interest||||73|23| |Cash held as part|ofthe investment||portfolio||11|20| |Total fixed asset|investments||||814|912| |13.Total gross income from investments||||and cash on deposit||| ||||||2023|2022| ||||||Total|Total| ||||||6000|FOOO| |Investments
lisled|on a recognised||Stock Exchange:|||| |UK Equities|||||11|14| |European
equities|||||3|0| |Overseas
and emerging||equities|||2|3| |Other investments:||||||| |UK fixed interest||||||| |UK Property||||||| |Alternative
Assets||||||| |Total|||||21|20| ## ||||2023|2022| |---|---|---|---|---| ||||Total|Total| ||||6000|6000| |Debtors under one year||||| |Investment
income|receivable|||| |Total||||| |15.Analysis ofcash||and deposits||| ||||2023|2022| ||||Total|Total| ||||6000|6000| |Shorl term investments||and deposits|1|| |Cash at bank and|in hand||10|| |Total||||| ## |16.Analy|s|is of liabilities|end com|mitments||| |---|---|---|---|---|---|---| ||||||2023|2022| ||||||Total|Total| ||||||8000|5000| |Creditors||&commitments|under|one year||| |Amounts|due to Liverpool||Women's|NHS||| |Foundation||Trust|||47|96| |Commitments|||||201|38| |Other accruals|||||0|2| |Total|||||248|136| ||||||2023|2022| ||||||Total|Total| ||||||6000|8000| |Creditors||&commitments|over one year|||| |Commitments|||||142|225| |Total|||||142|225| |||||||||||||2023|2022| |---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||||||||||Total|Total| |||||||||||||8000|8000| |Balance|at the start ofthe||reporting||period|||||||263|252| |Amounts|added
in current||period|||||||||275|95| |Amounts|charged against||commitments|||in the|current period|||||(194)|(84)| |Unused|amounts
reversed||during||the period|||||||(1)|0| |Balance|at the snd ofthe|reporting||period||||||||343|263| |17.Unrestricted
funds|||||||||||||| ||||||||Funds brought||Incoming||Resources|Loss on|Funds carried| |Analysis
ofunrestricted
designated
funds|||and material||||forward at
01-Apr-22||resources||expended|investments|forward at
31-Mar-23| |||||||||8000||f000|6000|6000|FOOO| |General|Purpose|||||||200||228|(208)|(40)|180| |Liverpool|Women's
Cancer Charity|||||||65||4|(18)|(7)|44| |Community
Midwifery||||||||31||11|(11)|(4)|27| |Reproductive
Medicine||Fund||||||10||0|(2)|(1)|7| |Medical|Education|||||||42||0|(10)|(4)|28| |Fetal Centre Research||&|Development|||Fund||32||5|(16)|(3)|18| |Neonatal|Fund|||||||155||81|(114)|(17)|105| |Other Funds||||||||27||35|(29)|(4)|29| |Total||||||||562||364|(408)|(80)|438| ||||||||||Funds brought|Incoming|Incoming|Resources|Gain on|Funds carried| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |Analysis
ofunrestricted
designated
funds|||||and material||||forward at
01-Apr-21|resources||expended|investments|forward at
31-Mar-22| ||||||||||6000||6000|6000|6000|6000| |General Purpose|||||||||140||130|(75)||200| |Liverpool|Women's|Cancer Charity|||||||74||10|(21)||65| |Community
Midwifery|||||||||34||7|(11)||31| |Reproductive
Medicine
Fund|||||||||2||3|5||10| |Medical Education|||||||||51||2|(12)||42| |Fetal Centre Research||||&|Development|||Fund|50||7|(26)||32| |Neonatal|Fund||||||||122||97|(68)||155| |Other Funds|||||||||31||23|(28)||27| |Total|||||||||504||279|(236)|15|562| |The purposes
ofthe||funds|||are given||in|note 3.||||||| |18.Reconciliation||ofnet|||movement|||in funds to net cash flow from||operating|activities|||| ||||||||||||||2023|2022| ||||||||||||||Total|Total| ||||||||||||||6000|6000| |Net movement
in funds|||||||||||||(124)|43| |Adjustments
for:||||||||||||||| |Dividends|and interest||on||investments||||||||(20)|(20)| |(Increase)|/ decrease||in|debtors|||||||||0|1| |Increase
/|(decrease)||in|creditors|||||||||29|(49)| |Total|||||||||||||(115)|(25)| |19.Analysis ofcash|||and||cash equivalents|||||||||| ||||||||||||||2023|2022| ||||||||||||||Total|Total| ||||||||||||||6000|6000| |Cash and|deposits:|||||||||||||| |Short term|investments||and deposits||||||||||10|| |Cashin hand|||||||||||||1|| ||||||||||||||21|8| |Cash held|as part ofthe|||investment||porffclic|||||||11|20| ||||||||||||||22|28| |20.Net Debt||||||||||||||| |2022/23:||||||||||||At 1 April 2022|Cashflows|At 31 March 2023| |||||||||||||6000|6000|6000| |Cash and|deposits|||||||||||28|(6)|22| |Loans due|within one||year|||||||||(96)|49|(47)| |Total||||||||||||(68)|43|(25)| |2021/22:||||||||||||At 1 April 2021|Cashflows|At 31 March 2022| |||||||||||||6000|6000|6000| |Cash and|deposits|||||||||||13|15|28| |Loans due|within one||year|||||||||(156)|60|(96)| |Total||||||||||||(143)|75|(68)| ## |||||||Unrestricted|Restricted|Total|Total| |---|---|---|---|---|---|---|---|---|---| |||||Note||Funds|Funds|Funds|Funds| |||||||2022|2022|2022|2021| |||||||6000|6000|5000|5000| |Incoming resources:|||||||||| |Income and endowments|from:||||||||| |Donations
and legacies||||||226||226|328| |Other trading
activities||||||33||33|5| |Investments|||||13|20||20|19| |Other income||||||0||0|0| |Total incoming
resources||||||279||279|352| |Resources expended;|||||||||| |Expenditure
on:|||||||||| |Raising funds||||||124||124|118| |Charitable
activities||||||112||112|229| |Total resources expended||||||236||236|347| |Net expenditure
before|investment||gains|||43||43|| |Net (loss) / gain on investments||—unrealised|||12|(52)||(52)|141| |Net gains on investments|-realised|||||67||67|19| |Net (expenditure)/income||||||58||58|165| |Net movement
in funds||||||58||58|165| |Reconciliation
ofFunds;|||||||||| |Fund balances
brought forward||1e April||||504||504|339| |Fund balances carried forward||31e|March|||562||562|504|